Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
Northwestern University
45,257 participants
Jan 30, 2024
INTERVENTIONAL
Conditions
Summary
Our study intends to offer 'real world' evidence of a viable, sustainable means to mobilize primary care via a comprehensive strategy for detecting cognitive impairment and dementias, advancing next steps for referral, and participating in the care planning and management of affected patients and caregivers. We will conduct a clinic-randomized, pragmatic trial testing the effectiveness and fidelity of our NIH Toolbox-derived paradigm to improve early detection and management of cognitive impairment/dementia in primary care settings serving health disparate patient populations.
Eligibility
Inclusion Criteria3
- been seen by an Oak Street healthcare provider affiliated with one of the 24 enrolled practices
- had at least one clinic visit (routine or Annual Wellness Visit) during the 3-year study period
- not been diagnosed previously with cognitive deficits, impairments or dementias.
Exclusion Criteria1
- Children, adolescence, and younger adults are excluded as cognitive impairment in these populations is often due to differences other than age-related changes.
Interventions
MyCog uses well-validated, self-administered, iPad-based measures from the NIH Toolbox for the Assessment of Neurological Behavior and Function Cognition Battery to provide an efficient and sensitive cognitive screen that can be easily implemented in primary care. Preliminary data shows these tests can discriminate between cognitively normal older adults and those with CI (specifically mild cognitive impairment); enabling physicians to assess CI in ways currently not available.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05607732